Evidence map›Paper›PMID 28380006›Full record

ArticlePloS one2017

Rapid tissue regeneration induced by intracellular ATP delivery-A preliminary mechanistic study.

Harshini Sarojini, Adrian T Billeter, Sarah Eichenberger, Devin Druen, Rebecca Barnett, Sarah A Gardner, Norman J Galbraith, Hiram C Polk, Sufan Chien

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Creating an Extremely Long-lasting Neuroischemic Wound Model.JID innovations : skin science from molecules to population health · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Macrophage mediation in normal and diabetic wound healing responses.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Harshini SarojiniDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.ORCID http://orcid.org/0000-0002-3103-9712
Adrian T BilleterDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Sarah EichenbergerDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Devin DruenDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Rebecca BarnettDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Sarah A GardnerDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Norman J GalbraithDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Hiram C PolkDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
Sufan ChienDepartment of Surgery, University of Louisville, Louisville, Kentucky, United States of America.
University of Louisville · US

Funding

A New Technique for Diabetic Foot UlcersR44DK105692 · NIDDK · NOVERATECH, LLC · PI CHIEN, SUFAN · 2016 to 2017
$1.5M
INTRACELLULAR ENERGY DELIVERY AND DIABETIC WOUNDSR01DK074566 · NIDDK · UNIVERSITY OF LOUISVILLE · PI CHIEN, SUFAN · 2007 to 2010
$1.3M
Partial-thickness wound healing via topical ATP deliveryR44AR052984 · NIAMS · NOVERA, LLC. · PI CHIEN, SUFAN · 2007 to 2008
$1.2M
A NEW TECHNIQUE FOR TREATING HEMORRHAGIC SHOCKR43HL114235 · NHLBI · NOVERATECH, LLC · PI CHIEN, SUFAN · 2012 to 2013
$400k
A new biomarker for diabetic foot ulcersR43DK104625 · NIDDK · NOVERATECH, LLC · PI CHIEN, SUFAN · 2015 to 2015
$281k
A new technique for diabetic foot ulcersR43DK105692 · NIDDK · NOVERATECH, LLC · PI CHIEN, SUFAN · 2015 to 2015
$275k
REDUCING LAPAROTOMY WOUND FAILURER43GM106639 · NIGMS · NOVERATECH, LLC · PI CHIEN, SUFAN · 2013 to 2013
$264k
NHLBI NIH HHS R43 HL114235NIAMS NIH HHS R44 AR052984NIDDK NIH HHS R01 DK074566NIDDK NIH HHS R43 DK104625NIDDK NIH HHS R43 DK105692NIDDK NIH HHS R44 DK105692NIGMS NIH HHS R43 GM106639
6 · The paper itself

Abstract

We have reported a new phenomenon in acute wound healing following the use of intracellular ATP delivery-extremely rapid tissue regeneration, which starts less than 24 h after surgery, and is accompanied by massive macrophage trafficking, in situ proliferation, and direct collagen production. This unusual process bypasses the formation of the traditional provisional extracellular matrix and significantly shortens the wound healing process. Although macrophages/monocytes are known to play a critical role in the initiation and progression of wound healing, their in situ proliferation and direct collagen production in wound healing have never been reported previously. We have explored these two very specific pathways during wound healing, while excluding confounding factors in the in vivo environment by analyzing wound samples and performing in vitro studies. The use of immunohistochemical studies enabled the detection of in situ macrophage proliferation in ATP-vesicle treated wounds. Primary human macrophages and Raw 264.7 cells were used for an in vitro study involving treatment with ATP vesicles, free Mg-ATP alone, lipid vesicles alone, Regranex, or culture medium. Collagen type 1α 1, MCP-1, IL-6, and IL-10 levels were determined by ELISA of the culture supernatant. The intracellular collagen type 1α1 localization was determined with immunocytochemistry. ATP-vesicle treated wounds showed high immunoreactivity towards BrdU and PCNA antigens, indicating in situ proliferation. Most of the cultured macrophages treated with ATP-vesicles maintained their classic phenotype and expressed high levels of collagen type 1α1 for a longer duration than was observed with cells treated with Regranex. These studies provide the first clear evidence of in situ macrophage proliferation and direct collagen production during wound healing. These findings provide part of the explanation for the extremely rapid tissue regeneration, and this treatment may hold promise for acute and chronic wound care.

Indexed as

Adenosine TriphosphateAnimalsChemokine CCL2Collagen Type ICollagen Type I, alpha 1 ChainHumansInterleukin-10Interleukin-6LiposomesMacrophagesMiceRAW 264.7 CellsTime FactorsWound HealingAdenosine TriphosphateChemokine CCL2Collagen Type ICollagen Type I, alpha 1 ChainInterleukin-10Interleukin-6Liposomes

Identifiers

PMID28380006
PMCPMC5381896
OpenAlexW2604475895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.